Form 4: Director David Dalvey Receives Celcuity Equity Grant

Director David Dalvey acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.

Summary

• Director David Dalvey was granted 1,530 restricted stock units (RSUs) of Celcuity Inc. common stock.
• The transaction occurred on June 5, 2026, at a price of $0 per share, representing an equity compensation award.
• The RSUs are scheduled to vest on the earlier of the 2027 annual meeting of stockholders or April 30, 2027.
• Following this transaction, David Dalvey holds 1,530 shares directly and maintains an indirect interest in 65,000 shares through Brightstone Venture Capital Fund, LP.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership in a biotechnology company.

Future Outlook

The restricted stock units are set to vest in 2027, aligning the director's long-term incentives with the company's performance leading up to the 2027 annual meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure board members have a vested interest in long-term company performance.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for publicly traded small-cap biotechnology firms.

Related Party Transactions

• The reporting person is the General Partner of Brightstone Venture Capital Fund, LP, which holds 65,000 shares of the issuer.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation award.

Next Steps

• Vesting of 1,530 restricted stock units by April 30, 2027, or the 2027 annual meeting of stockholders.

Key Dates

Keywords

Celcuity, CELC, Form 4, Insider Trading, Director Compensation, Equity Grant